Oculis (OCS) Institutional Ownership $17.61 -0.03 (-0.17%) As of 08/1/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Oculis (NASDAQ:OCS)CurrentInstitutional OwnershipPercentage22.30%Number ofInstitutional Buyers(last 12 months)12TotalInstitutional Inflows(last 12 months)$28.63MNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$3.60M Get OCS Insider Trade Alerts Want to know when executives and insiders are buying or selling Oculis stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data OCS Institutional Buying and Selling by Quarter Oculis Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails7/15/2025 Compagnie Lombard Odier SCmA97,000$1.88M0.0%+11.5%0.222% 5/16/2025Alyeska Investment Group L.P.131,332$2.50M0.0%N/A0.301% 5/14/2025Pivotal bioVenture Partners Investment Advisor LLC2,300,774$43.78M35.4%+32.4%5.270% 5/13/2025SR One Capital Management LP322,500$6.14M1.6%N/A0.739% 5/13/2025 Aberdeen Group plc1,253,119$23.85M0.0%+24.1%2.870% 5/5/2025Kestra Private Wealth Services LLC12,322$234K0.0%N/A0.028% 4/16/2025 Compagnie Lombard Odier SCmA87,000$1.66M0.0%-9.1%0.199% 2/17/2025Citadel Advisors LLC22,911$389K0.0%N/A0.057% 2/17/2025Bank of America Corp DE28,980$493K0.0%+58.2%0.072% 2/17/2025Bellevue Group AG10,000$170K0.0%N/A0.025% Get the Latest News and Ratings for OCS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oculis and its competitors with MarketBeat's FREE daily newsletter. 2/13/2025XTX Topco Ltd13,249$225K0.0%N/A0.033% 2/12/2025Geode Capital Management LLC16,744$284K0.0%+12.0%0.041% 1/24/2025 abrdn plc1,009,424$17.15M0.0%+23.0%2.492% 10/25/2024 abrdn plc820,553$10.06M0.0%-25.4%2.026% 5/14/2024Nan Fung Group Holdings Ltd436,378$5.26M4.9%-15.9%1.077% 2/14/2024Pivotal bioVenture Partners Investment Advisor LLC1,888,788$21.21M5.4%-14.9%5.190% 2/6/2024Searle & CO.10,000$112K0.0%N/A0.027% 1/31/2024 abrdn plc1,452,741$15.98M0.0%N/A3.992% 1/16/2024 Compagnie Lombard Odier SCmA95,750$1.05M0.0%+47.3%0.263% 11/14/2023Nan Fung Group Holdings Ltd606,684$6.67M5.4%-6.8%1.667% 11/14/2023Pivotal bioVenture Partners Investment Advisor LLC2,218,754$24.41M9.7%-6.8%6.097% 11/13/2023Wolverine Asset Management LLC7,021$77K0.0%N/A0.019% 9/21/2023Barclays PLC3,602$44K0.0%N/A0.010% 5/12/2023Nan Fung Group Holdings Ltd651,100$4.84M3.3%N/A1.989% 5/1/2023 Compagnie Lombard Odier SCmA65,000$472K0.0%N/A0.199% (Data available from 1/1/2016 forward) OCS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of OCS shares? During the previous two years, 16 institutional investors and hedge funds held shares of Oculis. The most heavily invested institutionals were Pivotal bioVenture Partners Investment Advisor LLC ($43.78M), Aberdeen Group plc ($23.85M), abrdn plc ($17.15M), SR One Capital Management LP ($6.14M), Nan Fung Group Holdings Ltd ($5.26M), Alyeska Investment Group L.P. ($2.50M), and Compagnie Lombard Odier SCmA ($1.88M).Learn more on Oculis' institutional investors. What percentage of Oculis' stock is owned by institutional investors? 22.30% of Oculis' stock is owned by institutional investors. Learn more on OCS's institutional investor holdings. Which institutional investors have been buying Oculis' stock? Of the 15 institutional investors that purchased Oculis' stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: abrdn plc ($1.64M), Pivotal bioVenture Partners Investment Advisor LLC ($563.08K), SR One Capital Management LP ($322.50K), Aberdeen Group plc ($243.70K), Alyeska Investment Group L.P. ($131.33K), Compagnie Lombard Odier SCmA ($40.75K), and Citadel Advisors LLC ($22.91K). How much institutional buying is happening at Oculis? Institutional investors have bought a total of 1,530,425 shares in the last 24 months. This purchase volume represents approximately $28.63M in transactions. Which of Oculis' major shareholders have been selling company stock? The following institutional investors have sold Oculis stock in the last 24 months: abrdn plc ($279.88K), and Compagnie Lombard Odier SCmA ($8.75K). How much institutional selling is happening at Oculis? Institutional investors have sold a total of 288,629 shares in the last 24 months. This volume of shares sold represents approximately $3.60M in transactions. Related Companies HCM Institutional Ownership KYMR Institutional Ownership CRNX Institutional Ownership IMVT Institutional Ownership ALVO Institutional Ownership MOR Institutional Ownership OGN Institutional Ownership NAMS Institutional Ownership RXRX Institutional Ownership RARE Institutional Ownership This page (NASDAQ:OCS) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredOne stock to replace NvidiaI'm a Futurist: Here are 3 stocks better than Nvidia Nvidia's own customers could soon become fierce compet...InvestorPlace | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oculis Holding AG Please log in to your account or sign up in order to add this asset to your watchlist. Share Oculis With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
